JAMP Pharma Corp. says it’s recalling one lot of its pregabalin ache treatment as a result of some bottles labelled to comprise 50-milligram capsules could comprise 150-milligram capsules as an alternative.
The mislabelled product might result in sufferers receiving a a lot bigger dose than prescribed, which might lead to an overdose and “pose critical, probably deadly well being dangers,” Well being Canada mentioned in a public advisory.
JAMP-Pregabalin is a prescription drug utilized in adults to deal with ache brought on by nerve harm as a consequence of diabetes, shingles or spinal twine harm, in addition to ache related to fibromyalgia.
Signs of pregabalin overdose could embrace sudden temper adjustments, sleepiness, confusion, despair, agitation, restlessness and seizures, the regulator mentioned.
Taking an excessive amount of pregabalin whereas additionally taking medicine that act on the central nervous system, together with opioids, has been related to coronary heart electrical issues, like arrhythmia, in addition to seizures and dying.
Well being Canada mentioned should you assume you’re experiencing signs of an overdose, search rapid medical consideration.
Sufferers mustn’t abruptly cease taking pregabalin, as this will lead to withdrawal signs, together with insomnia, nausea, headache, anxiousness, extreme sweating, diarrhea and convulsions.
When you’ve been prescribed 50-milligram capsules and the bottle incorporates the upper dose, or if you’re uncertain, return it to your pharmacy, Well being Canada suggested. In case you are unable to return your capsules to the pharmacy straight away, speak to your pharmacist or physician for additional steering.
The product was distributed nationally.
Source link